Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC-400: N-acetylcysteine in Liver Transplantation
NCT01866644Phase 3Completed
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- Sep 2011
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in primary graft dysfunction (PGD), sponsored by Health Research Institute Hospital La Fe. Started Sep 2011; status: completed.
02
Drugs
acetylcysteine
03
Conditions
primary graft dysfunction (PGD)
Beyond the preview
Go deeper on NCT01866644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01866644.